The latest closing stock price for Immunovant as of November 20, 2024 is 26.17.
An investor who bought $1,000 worth of Immunovant stock at the IPO in 2020 would have $539 today, roughly 1 times their original investment - a 9.01% compound annual growth rate over 5 years.
The all-time high Immunovant stock closing price was 52.71 on November 17, 2020.
The Immunovant 52-week high stock price is 45.58, which is 74.2% above the current share price.
The Immunovant 52-week low stock price is 24.61, which is 6% below the current share price.
The average Immunovant stock price for the last 52 weeks is 31.97.
An investor who bought $1,000 worth of Immunovant stock at the IPO in 2020 would have $539 today, roughly 1 times their original investment - a 9.01% compound annual growth rate over 5 years.
The all-time high Immunovant stock closing price was 52.71 on November 17, 2020.
The Immunovant 52-week high stock price is 45.58, which is 74.2% above the current share price.
The Immunovant 52-week low stock price is 24.61, which is 6% below the current share price.
The average Immunovant stock price for the last 52 weeks is 31.97.